Challenging homeostasis to define biomarkers for nutrition related health

Molecular Nutrition and Food Research

Volumn 53, Issue 7, 2009, Pages 795-804

  van Ommen, Ben ^a   Keijer, Jaap ^b   Heil, Sandra G ^b   Kaput, Jim ^c  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Biomarker; Challenge; Health; Homeostasis; Nutrition

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; HEALTH; HOMEOSTASIS; HUMAN; INDIVIDUALITY; NUTRITION; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; HEALTH; HOMEOSTASIS; HUMANS; INDIVIDUALITY; NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 68149164116     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800390     Document Type: Review

References (100)

1. Muller, M., Kersten, S., Nutrigenomics: goals and strategies. Nat. Rev. Genet. 2003, 4, 315-322.
2. van Ommen, B., Nutrigenomics: exploiting systems biology in the nutrition and health arenas. Nutrition 2004, 20, 4-8.
3. Lawton, K. A., Berger, A., Mitchell, M., Milgram, K. E., et al., Analysis of the adult human plasma metabolome. Pharmacogenomics 2008, 9, 383-397.
4. Bonassi, S., Neri, M., Puntoni, R., Validation of biomarkers as early predictors of disease. Mutat. Res. 2001, 480-481, 349-358.
5. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24, 971-983.
6. Maruvada, P., Srivastava, S., Joint National Cancer Institute-Food and Drug Administration workshop on research strategies, study designs, and statistical approaches to biomarker validation for cancer diagnosis and detection. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1078-1082.
7. Musaad, S., Haynes, E. N., Biomarkers of obesity and subsequent cardiovascular events. Epidemiol. Rev. 2007, 29, 98-114.
8. Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., Milzani, A., Biomarkers of oxidative damage in human disease. Clin. Chem 2006, 52, 601-623.
9. Rajaram, V., Pandhya, S., Patel, S., Meyer, P. M., et al., Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am. J. Cardiol. 2004, 93, 32C-48C.
10. Khuseyinova, N., Koenig, W., Biomarkers of outcome from cardiovascular disease. Curr. Opin. Crit. Care 2006, 12, 412-419.
11. Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., et al., DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007, 68, 812-819.
12. Shaw, L. M., Korecka, M., Clark, C. M., Lee, V. M., Trojanowski, J. Q., Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat. Rev. Drug Discov. 2007, 6, 295-303.
13. Ross, J. S., Symmans, W. F., Pusztai, L., Hortobagyi, G. N., Pharmacogenomics and clinical biomarkers in drug discovery and development. Am. J. Clin. Pathol. 2005, 124 (Suppl), S29-S41.
14. Ginsburg, G. S., Haga, S. B., Translating genomic biomarkers into clinically useful diagnostics. Expert Rev. Mol. Diagn. 2006, 6, 179-191.
15. He, Y. D., Genomic approach to biomarker identification and its recent applications. Cancer Biomark. 2006, 2, 103-133.
16. Wang, S. J., Cohen, N., Katz, D. A., Ruano, G., et al., Retrospective validation of genomic biomarkers - what are the questions, challenges and strategies for developing useful relationships to clinical outcomes - workshop summary. Pharmacogenomics J. 2006, 6, 82-88.
17. West, M., Ginsburg, G. S., Huang, A. T., Nevins, J. R., Embracing the complexity of genomic data for personalized medicine. Genome Res. 2006, 16, 559-566.
18. Malinowski, D. P., Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection. Expert Rev. Mol. Diagn. 2007, 7, 117-131.
19. Malinowski, D. P., Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management. Expert Rev. Mol. Diagn. 2007, 7, 269-280.
20. Fenech, M., Biomarkers of genetic damage for cancer epidemiology. Toxicology 2002, 181 - 182, 411-416.
21. Van Der Meer-Van Kraaij, C., Van Lieshout, E. M., Kramer, E., Van Der Meer, R., Keijer, J., Mucosal pentraxin (Mptx), a novel rat gene 10-fold down-regulated in colon by dietary heme. FASEB. J. 2003, 17, 1277-1285.
22. Mason, J. B., Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J. Nutr. 2003, 133 (Suppl 3), 941S-947S.
23. Gellekink, H., den Heijer, M., Heil, S. G., Blom, H. J., Genetic determinants of plasma total homocysteine. Semin. Vasc. Med. 2005, 5, 98-109.
24. Ordovas, J. M., The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins. Proc. Nutr. Soc. 2004, 63, 145-152.
25. Fuchs, D., Winkelmann, I., Johnson, I. T., Mariman, E., et al., Proteomics in nutrition research: principles, technologies and applications. Br. J. Nutr. 2005, 94, 302-314.
26. Kussmann, M., Affolter, M., Proteomic methods in nutrition. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9, 575-583.
27. Gibney, M. J., Walsh, M., Brennan, L., Roche, H. M., et al., Metabolomics in human nutrition: opportunities and challenges. Am. J. Clin. Nutr. 2005, 82, 497-503.
28. Garosi, P., De Filippo, C., van Erk, M., Rocca-Serra, P., et al., Defining best practice for microarray analyses in nutrigenomic studies. Br. J. Nutr. 2005, 93, 425-432.
29. Wilson, C., Schulz, S., Waldman, S. A., Biomarker development, commercialization, and regulation: individualization of medicine lost in translation. Clin. Pharmacol. Ther. 2007, 81, 153-155.
30. De Gruttola, V. G., Clax, P., DeMets, D. L., Downing, G. J., et al., Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control. Clin. Trials 2001, 22, 485-502.
31. Weir, C. J., Walley, R. J., Statistical evaluation of biomarkers as surrogate endpoints: a literature review. Stat. Med. 2006, 25, 183-203.
32. Lassere, M. N., Johnson, K. R., Boers, M., Tugwell, P., et al., Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. J. Rheumatol. 2007, 34, 607-615.
33. Ioannidis, J. P., Gwinn, M., Little, J., Higgins, J. P., et al., A road map for efficient and reliable human genome epidemiology. Nat. Genet. 2006, 38, 3-5.
34. Kaput, J., Perlina, A., Hatipoglu, B., Bartholomew, A., Nikolsky, Y., Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine. Pharmacogenomics 2007, 8, 369-390.
35. Arnold, C. N., Goel, A., Blum, H. E., Boland, C. R., Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 2005, 104, 2035-2047.
36. Murtaugh, M. A., Sweeney, C., Ma, K. N., Potter, J. D., et al., Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr. Cancer 2006, 55, 35-43.
37. Topping, D. L., Clifton, P. M., Short-chain fatty acids and human colonic function: roles of resistant starch and non-starch polysaccharides. Physiol. Rev. 2001, 81, 1031-1064.
38. Philpott, M., Ferguson, L. R., Immunonutrition and cancer. Mutat. Res. 2004, 551, 29-42.
39. Ferguson, L. R., Shelling, A. N., Browning, B. L., Huebner, C., Petermann, I., Genes, diet and inflammatory bowel disease. Mutat. Res. 2007, 622, 70-83.
40. Johnson, I. T., Lund, E. K., Review article: nutrition, obesity and colorectal cancer. Aliment. Pharmacol. Ther. 2007, 26, 161-181.
41. Sangha, S., Yao, M., Wolfe, M. M., Non-steroidal anti-inflammatory drugs and colorectal cancer prevention. Postgrad. Med. J. 2005, 81, 223-227.
42. Cottam, D. R., Mattar, S. G., Barinas-Mitchell, E., Eid, G., et al., The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes. Surg. 2004, 14, 589-600.
43. Farooqui, A. A., Horrocks, L. A., Farooqui, T., Modulation of inflammation in brain: a matter of fat. J. Neurochem. 2007, 101, 577-599.
44. Stumvoll, M., Control of glycaemia: from molecules to men. Minkowski Lecture 2003. Diabetologia 2004, 47, 770-781.
45. Wolford, J. K., Vozarova de Courten, B., Genetic basis of type 2 diabetes mellitus: implications for therapy. Treat. Endocrinol. 2004, 3, 257-267.
46. Kaput, J., Rodriguez, R. L., Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genomics 2004, 16, 166-177.
47. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., et al., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57, 1470-1481.
48. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772.
49. Kaput, J., Nutrigenomics research for personalized nutrition and medicine. Curr. Opin. Biotechnol. 2008, 19, 110-120.
50. Mathers, J. C., Early nutrition: impact on epigenetics. Forum Nutr. 2007, 60, 42-48.
51. Scarino, M., Do you remember your grandmother's food? How epigenetic changes transmit consequences of nutritional exposure from one generation to the next. Genes Nutr. 2008, 3, 1-3.
52. van Erk, M. J., Blom, W. A., van Ommen, B., Hendriks, H. F., High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. Am. J. Clin. Nutr. 2006, 84, 1233-1241.
53. Walsh, M. C., Brennan, L., Malthouse, J. P., Roche, H. M., Gibney, M. J., Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am. J. Clin. Nutr. 2006, 84, 531-539.
54. Walsh, M. C., Brennan, L., Pujos-Guillot, E., Sebedio, J. L., et al., Influence of acute phytochemical intake on human urinary metabolomic profiles. Am. J. Clin. Nutr. 2007, 86, 1687-1693.
55. Talwar, D. K., Azharuddin, M. K., Williamson, C., Teoh, Y. P., et al., Biological variation of vitamins in blood of healthy individuals. Clin. Chem. 2005, 51, 2145-2150.
56. Berrahmoune, H., Lamont, J., Fitzgerald, P., Visvikis-Siest, S., Inter-individual variation of inflammatory markers of cardiovascular risks and diseases. Clin. Chem. Lab Med 2005, 43, 671-684.
57. Kao, P. C., Shiesh, S. C., Wu, T. J., Serum C-reactive protein as a marker for wellness assessment. Ann. Clin. Lab. Sci. 2006, 36, 163-169.
58. Nedelkov, D., Population proteomics: investigation of protein diversity in human populations. Proteomics 2008, 8, 779-786.
59. Bernard, C., Lecons sur les phenomenes de la vie communs aux animaux et aux vegetaux. J. Vrin. Paris, Librairee philosphique 1866.
60. Cannon, W., Organization for physiological homeostasis. Physiol. Rev. 1929, 9, 399-431.
61. Young, V. R., Trace element biology: the knowledge base and its application for the nutrition of individuals and populations. J. Nutr. 2003, 133, 1581S-1587S.
62. Leiter, L. A., Ceriello, A., Davidson, J. A., Hanefeld, M., et al., Postprandial glucose regulation: new data and new implications. Clin. Ther. 2005, 27 Suppl B, S42-56.
63. American Diabetes Association, Screening for type 2 diabetes. Diabetes Care 2003, 26 (Suppl 1), S21-24.
64. Goldstein, D. E., Little, R. R., Lorenz, R. A., Malone, J. I., et al., Tests of glycemia in diabetes. Diabetes Care 2004, 27, 1761-1773.
65. Eddy, D. M., Schlessinger, L., Kahn, R., Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann. Intern. Med. 2005, 143, 251-264.
66. Katterle, Y., Keipert, S., Hof, J., Klaus, S., Dissociation of obesity and insulin resistance in transgenic mice with skeletal muscle expression of uncoupling protein 1. Physiol. Genomics 2008, 32, 352-359.
67. Ronnemaa, E., Zethelius, B., Sundelof, J., Sundstrom, J., et al., Impaired insulin secretion increases the risk of Alzheimer disease. Neurology 2008, 71, 1065-1071.
68. Bansal, S., Buring, J. E., Rifai, N., Mora, S., et al., Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Jama 2007, 298, 309-316.
69. Nordestgaard, B. G., Benn, M., Schnohr, P., Tybjaerg-Hansen, A., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama 2007, 298, 299-308.
70. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., et al., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127, 1109-1122.
71. Abdel-Sayed, A., Binnert, C., Le, K. A., Bortolotti, M., et al., A high-fructose diet impairs basal and stress-mediated lipid metabolism in healthy male subjects. Br. J. Nutr. 2008, 100, 393-399.
72. Freeman, J. V., Dewey, F. E., Hadley, D. M., Myers, J., Froelicher, V. F., Autonomic nervous system interaction with the cardiovascular system during exercise. Prog. Cardiovasc. Dis. 2006, 48, 342-362.
73. Orhan, H., van Holland, B., Krab, B., Moeken, J., et al., Evaluation of a multi-parameter biomarker set for oxidative damage in man: increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise. Free Radic. Res. 2004, 38, 1269-1279.
74. Lippi, G., Brocco, G., Franchini, M., Schena, F., Guidi, G., Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls. Clin. Chem. Lab. Med. 2004, 42, 644-647.
75. Campbell, K. L., McTiernan, A., Exercise and biomarkers for cancer prevention studies. J. Nutr. 2007, 137, 161S-169S.
76. Kasapis, C., Thompson, P. D., The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J. Am. Coll. Cardiol. 2005, 45, 1563-1569.
77. Rao, C. V., Wolf, D. M., Arkin, A. P., Control, exploitation and tolerance of intracellular noise. Nature 2002, 420, 231-237.
78. Kitano, H., Oda, K., Kimura, T., Matsuoka, Y., et al., Metabolic syndrome and robustness tradeoffs. Diabetes 2004, 53 (Suppl 3), S6-S15.
79. Kitano, H., Oda, K., Robustness trade-offs and host-microbial symbiosis in the immune system. Mol. Syst. Biol. 2006, 2, 1-10.
80. Csete, M., Doyle, J., Bow ties, metabolism and disease. Trends Biotechnol. 2004, 22, 446-450.
81. Schroder, M., Endoplasmic reticulum stress responses. Cell Mol. Life Sci. 2008, 65, 862-894.
82. Bouwens, M., Afman, L. A., Muller, M., Fasting induces changes in peripheral blood mononuclear cell gene expression profiles related to increases in fatty acid beta-oxidation: functional role of peroxisome proliferator activated receptor alpha in human peripheral blood mononuclear cells. Am. J. Clin. Nutr. 2007, 86, 1515-1523.
83. Sparks, L. M., Xie, H., Koza, R. A., Mynatt, R., et al., A highfat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005, 54, 1926-1933.
84. LaRosa, P. C., Miner, J., Xia, Y., Zhou, Y., et al., Trans-10, cis-12 conjugated linoleic acid causes inflammation and delipidation of white adipose tissue in mice: a microarray and histological analysis. Physiol. Genomics 2006, 27, 282-294.
85. de Vogel-van den Bosch, H. M., Bunger, M., de Groot, P. J., Bosch-Vermeulen, H., et al., PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression. BMC Genomics 2008, 9, 231.
86. Qian, W. J., Monroe, M. E., Liu, T., Jacobs, J. M., et al., Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol. Cell Proteomics 2005, 4, 700-709.
87. Moschos, S. A., Williams, A. E., Perry, M. M., Birrell, M. A., et al., Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 2007, 8, 240.
88. Kuhl, J. M. T., Wagner, H., Stenlund, H., Lundgren, K., Bavenholm, P., Efendic, S., Norstedt, G., Tollet-Egnell, P., Metabolomics as a tool to evaluate exercise-induced improvements in insulin sensitivity. Metabolomics 2008, 4, 273-282.
89. Shaham, O., Wei, R., Wang, T. J., Ricciardi, C., et al., Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol. Syst. Biol. 2008, 4, 214.
90. Williams, R. P., Biochemical individuality: The basis for the genetotrophic concept, The McGraw Hill companies, Columbus, OH 1956.
91. Boorsma, A., Foat, B. C., Vis, D., Klis, F., Bussemaker, H. J., T-profiler: scoring the activity of predefined groups of genes using gene expression data. Nucleic Acids Res. 2005, 33, W592-595.
92. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102, 15545-15550.
93. Cavalieri, D., Castagnini, C., Toti, S., Maciag, K., et al., Eu.Gene Analyzer a tool for integrating gene expression data with pathway databases. Bioinformatics 2007, 23, 2631-2632.
94. Rodin, A. S., Boerwinkle, E., Mining genetic epidemiology data with Bayesian networks I: Bayesian networks and example application (plasma apoE levels). Bioinformatics 2005, 21, 3273-3278.
95. Djebbari, A., Quackenbush, J., Seeded Bayesian Networks: constructing genetic networks from microarray data. BMC Syst. Biol. 2008, 2, 57.
96. Adourian, A., Jennings, E., Balasubramanian, R., Hines, W. M., et al., Correlation network analysis for data integration and biomarker selection. Mol. Biosyst. 2008, 4, 249-259.
97. Rodenburg, W., Heidema, A. G., Boer, J. M., Bovee-Oudenhoven, I. M., et al., A framework to identify physiological responses in microarray-based gene expression studies: selection and interpretation of biologically relevant genes. Physiol. Genomics 2008, 33, 78-90.
98. Recordati, G., Bellini, T. G., A definition of internal constancy and homeostasis in the context of non-equilibrium thermodynamics. Exp. Physiol. 2004, 89, 27-38.
99. Calabrese, E. J., Baldwin, L. A., Hormesis: the dose-response revolution. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 175-197.
100. Zeisel, S. H., Freake, H. C., Bauman, D. E., Bier, D. M., et al., The nutritional phenotype in the age of metabolomics. J. Nutr. 2005, 135, 1613-1616.